Drugs / Dilatrend SR capsule 32mg
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01819870 | Apr → May 2013 | congestive heart failure, essential hypertension, intermediate coronary syndrome | Chong Kun Dang Pharmaceutical | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dilatrend SR capsule 32mg | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01819870 ↗ |
| Route | Oral | “* 1 capsule, oral, once daily, 7days” NCT01819870 ↗ |